References
- Lech M, Kulkarni OP, Pfeiffer S, Savarese E, Krug A, Garlanda C, et al. Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus AAg. J Exp Med 2008; 205: 1879–1888
- Burlingame RW, Boey ML, Starkebaum G, Rubin RL. The central role of chromatin in autoimmune responses to histones and DNA in SLE. J Clin Invest 1994; 94: 184–192
- Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the Nuc core particle at 2.8 Å resolution. Nature 1997; 389: 251–260
- Rumore PM, Steinman CR. Endogenous circulating DNA in SLE. Occurrence as multimeric complexes bound to histone. J Clin Invest 1990; 86: 69–74
- Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apo cell material by Mo-derived MΦ from patients with SLE. Arthritis Rheum 1998; 41: 1241–1250
- Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG, Moroy T. Features of SLE in DNase1-deficient mice. Nat Genet 2000; 25: 177–181
- Bickerstaff MC, Botto M, Hutchinson WL, Herbert J, Tennent GA, Bybee A, et al. SAP component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med 1999; 5: 694–697
- Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, et al. Homozygous C1q deficiency causes GN associated with multiple apo bodies. Nat Genet 1998; 19: 56–59
- Desai-Mehta A, Mao C, Rajagopalan S, Robinson T, Datta SK. Structure and specificity of TCR expressed by potentially pathogenic anti-DNA AAb-inducing TC in human lupus. J Clin Invest 1995; 95: 531–541
- Chabre H, Amoura Z, Piette JC, Godeau P, Bach JF, Koutouzov S. Presence of Nuc-restricted Ab in patients with SLE. Arthritis Rheum 1995; 38: 1485–1491
- Decker P. Nuc AAb. Clin Chim Acta 2006; 366: 48–60
- Ding D, Mehta H, McCune WJ, Kaplan MJ. Aberrant phenotype and function of myeloid DC in SLE. J Immunol 2006; 177: 5878–5889
- Decker P, Kötter I, Klein R, Berner B, Rammensee HG. MdDC over-express CD86 in patients with SLE. Rheumatology (Oxford) 2006; 45: 1087–1095
- Molad Y, Buyon J, Anderson DC, Abramson SB, Cronstein BN. Intravascular Nph activation in SLE: Dissociation between increased expression of CD11b/CD18 and diminished expression of L-selectin on Nph from patients with active SLE. Clin Immunol Immunopathol 1994; 71: 281–286
- Rifkin IR, Leadbetter EA, Busconi L, Viglianti G, Marshak-Rothstein A. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol Rev 2005; 204: 27–42
- Hefeneider SH, Cornell KA, Brown LE, Bakke AC, McCoy SL, Bennett RM. Nuc and DNA bind to specific cell-surface molecules on murine cells and induce cytokine production. Clin Immunol Immunopathol 1992; 63: 245–251
- Decker P, Singh-Jasuja H, Haager S, Kötter I, Rammensee HG. Nuc, the main AAg in SLE, induces direct DC activation via a MyD88-independent pathway: Consequences on inflammation. J Immunol 2005; 174: 3326–3334
- Rönnefarth VM, Erbacher AIM, Lamkemeyer T, Madlung J, Nordheim A, Rammensee HG, et al. TLR2/TLR4-independent Nph activation and recruitment upon endocytosis of Nuc reveals a new pathway of innate immunity in SLE. J Immunol 2006; 177: 7740–7749
- Strainic MG, Liu J, Huang D, An F, Lalli PN, Muqim N, et al. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ TC. Immunity 2008; 28: 425–435
- Coritsidis GN, Lombardo F, Rumore P, Kuo SF, Izzo R, Mir R, et al. Nuc effects on mesangial cell matrix and proliferation: A possible role in early lupus nephritis. Exp Nephrol 2002; 10: 216–226
- Grootscholten C, van Bruggen MC, van der Pijl JW, de Jong EM, Ligtenberg G, Derksen RH, et al. Deposition of Nuc Ag (histones and DNA) in the epidermal basement membrane in human lupus nephritis. Arthritis Rheum 2003; 48: 1355–1362